The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Patou Gary | Director | Sell(S) | 1K | $53.14 | $70K |
| Jun 5, 2026 | Cannon Gillian | Director | Sell(S) | 1K | $53.14 | $63K |
| Jun 3, 2026 | Patou Gary | Director | Grant(A) | 11K | — | $0 |
| Jun 3, 2026 | Patou Gary | Director | Grant(A) | 2K | — | $0 |
| Jun 3, 2026 | Machado Patrick | Director | Grant(A) | 11K | — | $0 |
| Jun 3, 2026 | Machado Patrick | Director | Grant(A) | 2K | — | $0 |
| Jun 3, 2026 | Gover Justin D. | Director | Grant(A) | 11K | — | $0 |
| Jun 3, 2026 | Gover Justin D. | Director | Grant(A) | 2K | — | $0 |
| Jun 3, 2026 | Garofalo Elizabeth A. | Director | Grant(A) | 11K | — | $0 |
| Jun 3, 2026 | Garofalo Elizabeth A. | Director | Grant(A) | 2K | — | $0 |
| Jun 3, 2026 | Gannon Steven | Director | Grant(A) | 11K | — | $0 |
| Jun 3, 2026 | Gannon Steven | Director | Grant(A) | 2K | — | $0 |
| Jun 3, 2026 | Cannon Gillian | Director | Grant(A) | 11K | — | $0 |
| Jun 3, 2026 | Cannon Gillian | Director | Grant(A) | 2K | — | $0 |
| Jun 3, 2026 | Svoronos Dawn | Director | Grant(A) | 11K | — | $0 |
| Jun 3, 2026 | Svoronos Dawn | Director | Grant(A) | 2K | — | $0 |
| Jun 1, 2026 | Patou Gary | Director | Option exercise(M) | 3K | — | — |
| Jun 1, 2026 | Patou Gary | Director | Option exercise(M) | 3K | — | $0 |
| Jun 1, 2026 | Machado Patrick | Director | Option exercise(M) | 3K | — | — |
| Jun 1, 2026 | Machado Patrick | Director | Option exercise(M) | 3K | — | $0 |
| Jun 1, 2026 | Gover Justin D. | Director | Option exercise(M) | 3K | — | — |
| Jun 1, 2026 | Gover Justin D. | Director | Option exercise(M) | 3K | — | $0 |
| Jun 1, 2026 | Garofalo Elizabeth A. | Director | Option exercise(M) | 3K | — | — |
| Jun 1, 2026 | Garofalo Elizabeth A. | Director | Option exercise(M) | 3K | — | $0 |
| Jun 1, 2026 | Gannon Steven | Director | Option exercise(M) | 3K | — | — |
| Jun 1, 2026 | Gannon Steven | Director | Tax withholding(F) | 1K | $53.41 | $76K |
| Jun 1, 2026 | Gannon Steven | Director | Option exercise(M) | 3K | — | $0 |
| Jun 1, 2026 | Cannon Gillian | Director | Option exercise(M) | 3K | — | — |
| Jun 1, 2026 | Cannon Gillian | Director | Option exercise(M) | 3K | — | $0 |
| Jun 1, 2026 | Svoronos Dawn | Director | Option exercise(M) | 3K | — | — |
| Jun 1, 2026 | Svoronos Dawn | Director | Tax withholding(F) | 1K | $53.41 | $76K |
| Jun 1, 2026 | Svoronos Dawn | Director | Option exercise(M) | 3K | — | $0 |
| May 12, 2026 | Gannon Steven | Director | Option exercise(M) | 4K | — | $0 |
| May 12, 2026 | Gannon Steven | Director | Option exercise(M) | 4K | $7.38 | $26K |
| Mar 13, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 7K | $55.23 | $404K |
| Mar 13, 2026 | DiFabio Andrea | Chief Legal Officer | Sell(S) | 1K | $55.23 | $74K |
| Mar 13, 2026 | Kenney Christopher John | Chief Medical Officer | Sell(S) | 1K | $55.23 | $78K |
| Mar 12, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 13K | — | — |
| Mar 12, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 13K | — | $0 |
| Mar 12, 2026 | DiFabio Andrea | Chief Legal Officer | Option exercise(M) | 4K | — | — |
| Mar 12, 2026 | DiFabio Andrea | Chief Legal Officer | Option exercise(M) | 4K | — | $0 |
| Mar 12, 2026 | Kenney Christopher John | Chief Medical Officer | Option exercise(M) | 4K | — | — |
| Mar 12, 2026 | Kenney Christopher John | Chief Medical Officer | Option exercise(M) | 4K | — | $0 |
| Mar 10, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 11K | $60.11 | $677K |
| Mar 10, 2026 | DiFabio Andrea | Chief Legal Officer | Sell(S) | 3K | $60.11 | $157K |
| Mar 10, 2026 | Kenney Christopher John | Chief Medical Officer | Sell(S) | 3K | $60.11 | $167K |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 75K | $8.40 | $630K |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 22K | $58.81 | $1.3M |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 32K | $59.88 | $1.9M |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 22K | $60.49 | $1.3M |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 25K | $3.10 | $78K |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 12K | $59.50 | $743K |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 10K | $60.47 | $609K |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 2K | $61.26 | $150K |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 105K | $4.75 | $499K |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 43K | $59.26 | $2.6M |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 62K | $60.08 | $3.7M |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 65K | $9.44 | $614K |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 65K | $62.06 | $4.0M |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 20K | — | — |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 65K | — | $0 |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 75K | — | $0 |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 105K | — | $0 |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 20K | — | $0 |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Grant(A) | 20K | — | $0 |
| Mar 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 25K | — | $0 |
| Mar 9, 2026 | DiFabio Andrea | Chief Legal Officer | Option exercise(M) | 8K | — | — |
| Mar 9, 2026 | DiFabio Andrea | Chief Legal Officer | Option exercise(M) | 8K | — | $0 |
| Mar 9, 2026 | DiFabio Andrea | Chief Legal Officer | Grant(A) | 8K | — | $0 |
| Mar 9, 2026 | Kenney Christopher John | Chief Medical Officer | Option exercise(M) | 8K | — | — |
| Mar 9, 2026 | Kenney Christopher John | Chief Medical Officer | Option exercise(M) | 8K | — | $0 |
| Mar 9, 2026 | Kenney Christopher John | Chief Medical Officer | Grant(A) | 8K | — | $0 |
| Jan 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Grant(A) | 65K | — | $0 |
| Jan 9, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Grant(A) | 350K | — | $0 |
| Jan 9, 2026 | DiFabio Andrea | Chief Legal Officer | Grant(A) | 15K | — | $0 |
| Jan 9, 2026 | DiFabio Andrea | Chief Legal Officer | Grant(A) | 80K | — | $0 |
| Jan 9, 2026 | Cline Darren S | Chief Commercial Officer | Grant(A) | 20K | — | $0 |
| Jan 9, 2026 | Cline Darren S | Chief Commercial Officer | Grant(A) | 40K | — | $0 |
| Jan 9, 2026 | Kenney Christopher John | Chief Medical Officer | Grant(A) | 20K | — | $0 |
| Jan 9, 2026 | Kenney Christopher John | Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Jan 2, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 38K | $44.40 | $1.7M |
| Jan 2, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 40K | $7.49 | $300K |
| Jan 2, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 2K | $44.93 | $93K |
| Jan 2, 2026 | Mortimer Ian | PRESIDENT & CEO, Director | Option exercise(M) | 40K | — | $0 |
| Dec 8, 2025 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 2K | $46.32 | $93K |
| Dec 8, 2025 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 9K | $45.59 | $402K |
| Dec 5, 2025 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 14K | $45.03 | $647K |
| Nov 28, 2025 | Mortimer Ian | PRESIDENT & CEO, Director | Sell(S) | 97 | $45.01 | $4K |
| Oct 15, 2025 | Kelly Thomas Patrick | Chief Financial Officer | Grant(A) | 225K | — | $0 |
| Oct 15, 2025 | Kelly Thomas Patrick | Chief Financial Officer | Grant(A) | 30K | — | $0 |
| Oct 1, 2025 | Mortimer Ian | PRESIDENT, CEO & INTERIM CFO, Director | Sell(S) | 25K | $40.16 | $1.0M |
| Oct 1, 2025 | Mortimer Ian | PRESIDENT, CEO & INTERIM CFO, Director | Option exercise(M) | 25K | $7.69 | $192K |
| Oct 1, 2025 | Mortimer Ian | PRESIDENT, CEO & INTERIM CFO, Director | Option exercise(M) | 25K | — | $0 |
| Jun 23, 2025 | Cline Darren S | Chief Commercial Officer | Grant(A) | 186K | — | $0 |
| Jun 5, 2025 | Svoronos Dawn | Director | Grant(A) | 3K | — | $0 |
| Jun 5, 2025 | Svoronos Dawn | Director | Grant(A) | 17K | — | $0 |
| Jun 5, 2025 | Cannon Gillian | Director | Grant(A) | 3K | — | $0 |
| Jun 5, 2025 | Cannon Gillian | Director | Grant(A) | 17K | — | $0 |
| Jun 5, 2025 | Gannon Steven | Director | Sell(S) | 3 | $30.48 | $91 |
| Jun 5, 2025 | Gannon Steven | Director | Grant(A) | 17K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).